Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-02-11 10:03 am Purchase | 2021-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY | Avoro Capital Advisors LLC | 12,800,000 14.700% | 2,500,000![]() (+24.27%) | Filing History |
2022-02-11 10:02 am Purchase | 2021-12-31 | 13G | United Therapeutics Corporation UTHR | Avoro Capital Advisors LLC | 3,035,000 6.700% | 185,000![]() (+6.49%) | Filing History |
2022-02-11 10:01 am Sale | 2021-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM | Avoro Capital Advisors LLC | 695,000 7.100% | -105,000![]() (-13.12%) | Filing History |
2022-02-11 10:01 am Purchase | 2021-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Avoro Capital Advisors LLC | 3,235,000 8.800% | 2,858![]() (+0.09%) | Filing History |
2022-02-11 10:01 am Purchase | 2021-12-31 | 13G | Mirati Therapeutics, Inc. MRTX | Avoro Capital Advisors LLC | 5,075,000 9.200% | 540,000![]() (+11.91%) | Filing History |
2022-02-11 10:00 am Purchase | 2021-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | Avoro Capital Advisors LLC | 4,985,000 9.700% | 2,185,000![]() (+78.04%) | Filing History |
2021-11-24 3:48 pm Sale | 2021-11-22 | 13D | Acceleron Pharma Inc. XLRN | Avoro Capital Advisors LLC | 0 0.000% | -4,476,100![]() (Position Closed) | Filing History |
2021-10-05 12:30 pm Purchase | 2021-09-30 | 13D | Acceleron Pharma Inc. XLRN | Avoro Capital Advisors LLC | 4,476,100 7.300% | 4,476,100![]() (New Position) | Filing History |
2021-08-30 5:27 pm Purchase | 2021-08-26 | 13D | Whitehawk Therapeutics Inc WHWK | Avoro Capital Advisors LLC | 2,211,752 10.700% | 2,211,752![]() (New Position) | Filing History |
2021-06-04 08:30 am Purchase | 2021-05-27 | 13D | Aerpio Pharmaceuticals, Inc. ARPO | Avoro Capital Advisors LLC | 300,000 9.500% | 300,000![]() (New Position) | Filing History |
2021-02-12 08:14 am Purchase | 2020-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS | Avoro Capital Advisors LLC | 3,232,142 9.090% | 3,232,142![]() (New Position) | Filing History |
2021-02-12 08:14 am Purchase | 2020-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | Avoro Capital Advisors LLC | 2,800,000 8.000% | 400,000![]() (+16.67%) | Filing History |
2021-02-12 08:13 am Sale | 2020-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI | Avoro Capital Advisors LLC | 0 0.000% | -393,333![]() (Position Closed) | Filing History |
2021-02-12 08:13 am Sale | 2020-12-31 | 13G | Cue Biopharma, Inc. CUE | Avoro Capital Advisors LLC | 452,500 1.500% | -1,417,500![]() (-75.80%) | Filing History |
2021-02-12 08:12 am Sale | 2020-12-31 | 13G | Athenex, Inc. ATNX | Avoro Capital Advisors LLC | 18,625 0.400% | -244,447![]() (-92.92%) | Filing History |
2021-02-12 08:11 am Sale | 2020-12-31 | 13G | Alimera Sciences, Inc. ALIM | Avoro Capital Advisors LLC | 0 0.000% | -415,999![]() (Position Closed) | Filing History |
2021-02-12 08:11 am Purchase | 2020-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP | Avoro Capital Advisors LLC | 2,350,267 5.300% | 2,350,267![]() (New Position) | Filing History |
2021-02-12 08:10 am Purchase | 2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA | Avoro Capital Advisors LLC | 1,000,000 7.100% | 1,000,000![]() (New Position) | Filing History |
2021-02-12 08:09 am Purchase | 2020-12-31 | 13G | Trillium Therapeutics Inc. TRIL | Avoro Capital Advisors LLC | 5,800,000 5.700% | 5,800,000![]() (New Position) | Filing History |
2021-02-12 08:09 am Purchase | 2020-12-31 | 13G | Kura Oncology, Inc. KURA | Avoro Capital Advisors LLC | 4,000,000 6.200% | 4,000,000![]() (New Position) | Filing History |